155 related articles for article (PubMed ID: 22146771)
1. Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival.
Giuntoli RL; Gerardi MA; Yemelyanova AV; Ueda SM; Fleury AC; Diaz-Montes TP; Bristow RE
Int J Gynecol Cancer; 2012 Feb; 22(2):273-9. PubMed ID: 22146771
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system.
Seward S; Ali-Fehmi R; Munkarah AR; Semaan A; Al-Wahab ZR; Elshaikh MA; Cote ML; Morris RT; Bandyopadhyay S
Int J Gynecol Cancer; 2012 Mar; 22(3):452-6. PubMed ID: 22274544
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.
Tate K; Yoshida H; Ishikawa M; Uehara T; Ikeda SI; Hiraoka N; Kato T
J Gynecol Oncol; 2018 May; 29(3):e34. PubMed ID: 29533019
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of adjuvant chemotherapy and vaginal brachytherapy with or without pelvic radiation for surgical stage I-II uterine serous carcinoma.
Robbins JR; Siddiqui MS; Al-Wahab Z; Laser B; Lu M; Ali-Fehmi R; Munkarah A; Elshaikh MA
Eur J Gynaecol Oncol; 2012; 33(5):449-54. PubMed ID: 23185785
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis, treatment and prognosis of uterine serous carcinoma].
Zhang F; Deng LS; Li B; Huang MN; Li XG; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):848-856. PubMed ID: 33355760
[No Abstract] [Full Text] [Related]
6. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
[TBL] [Abstract][Full Text] [Related]
7. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
[TBL] [Abstract][Full Text] [Related]
8. Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study.
Boyraz G; Salman MC; Basaran D; Ozgul N; Turan T; Turkmen O; Kimyon GC; Ozkan NT; Cagan M; Gungor T; Meydanli MM; Gungorduk K; Gulseren V; Sanci M; Yuce K
Int J Gynecol Cancer; 2017 Jan; 27(1):102-108. PubMed ID: 27668395
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in surgical stage I uterine papillary serous carcinoma.
Havrilesky LJ; Secord AA; Bae-Jump V; Ayeni T; Calingaert B; Clarke-Pearson DL; Berchuck A; Gehrig PA
Gynecol Oncol; 2007 Jun; 105(3):677-82. PubMed ID: 17355889
[TBL] [Abstract][Full Text] [Related]
10. The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish study.
Cakir C; Kilic F; Kilic C; Tokgozoglu N; Ersak B; Ayhan S; Akar S; Yuksel D; Korkmaz V; Boran N; Toptas T; Kimyon Comert G; Ureyen I; Tasci T; Turkmen O; Moraloglu Tekin O; Ustun Y; Turan T
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102063. PubMed ID: 33453448
[TBL] [Abstract][Full Text] [Related]
11. Distribution and volume of extrauterine disease in uterine serous carcinoma: is minimally invasive surgery a suitable approach?
Ayeni TA; AlHilli MM; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; Cliby WA; Keeney GL; Podratz KC; Dowdy SC
Int J Gynecol Cancer; 2015 Jan; 25(1):87-91. PubMed ID: 25474625
[TBL] [Abstract][Full Text] [Related]
12. Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study.
Winer I; Mahdi H; Bandyopadhyay S; Semaan A; Van de Vijver KK; Nucci MR; Abdul-Karim F; Hussein Y; Qureshi F; Hayek K; Alosh B; Schulz D; Cote M; Munkarah A; Morris R; Oliva E; Ali-Fehmi R
Gynecol Oncol; 2013 Feb; 128(2):316-21. PubMed ID: 23138135
[TBL] [Abstract][Full Text] [Related]
13. Population-based treatment and outcomes of Stage I uterine serous carcinoma.
van der Putten LJ; Hoskins P; Tinker A; Lim P; Aquino-Parsons C; Kwon JS
Gynecol Oncol; 2014 Jan; 132(1):61-4. PubMed ID: 24219983
[TBL] [Abstract][Full Text] [Related]
14. Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study.
Mahdi H; Elshaikh MA; DeBenardo R; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; Moslemi-Kebria M
Gynecol Oncol; 2015 May; 137(2):239-44. PubMed ID: 25641568
[TBL] [Abstract][Full Text] [Related]
15. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
16. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review.
Growdon WB; Rauh-Hain JJ; Cordon A; Garrett L; Schorge JO; Goodman A; Boruta DM; Horowitz NS; del Carmen MG
Int J Gynecol Cancer; 2012 Mar; 22(3):417-24. PubMed ID: 22237383
[TBL] [Abstract][Full Text] [Related]
17. Is a More Comprehensive Surgery Necessary in Patients With Uterine Serous Carcinoma?
Touhami O; Trinh XB; Gregoire J; Sebastianelli A; Renaud MC; Grondin K; Plante M
Int J Gynecol Cancer; 2015 Sep; 25(7):1266-70. PubMed ID: 26067862
[TBL] [Abstract][Full Text] [Related]
18. Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.
Zhang M; Yang TJ; Desai NB; DeLair D; Kollmeier MA; Makker V; Leitao MM; Abu-Rustum NR; Alektiar KM
Brachytherapy; 2019; 18(1):38-43. PubMed ID: 30316723
[TBL] [Abstract][Full Text] [Related]
19. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
Boruta DM; Gehrig PA; Groben PA; Bae-Jump V; Boggess JF; Fowler WC; Van Le L
Cancer; 2004 Nov; 101(10):2214-21. PubMed ID: 15452833
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]